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General Methods
All reagents and solvents were commercially available and were used without further purification unless otherwise stated. All reactions sensitive to air or moisture were carried out under argon atmosphere in dry, freshly distilled solvents under anhydrous conditions. DMSO-d 6 and CDCl 3 (99.8 %D) were stored on molecular sieves (3 Å). 1 H and 13 C NMR spectra were recorded at 600, 300 and 75 MHz at 23 ºC unless otherwise specified. Chemicals shifts are reported as parts per million (δ) referenced to the residual deuterium lock solvents. The coupling constants values J are given in Hz. NMR peak assignments were performed by COSY, HSQC, HMBC, and NOESY experiments. Concentration dependence experiments were run recording spectra of the studied compounds at seven different concentrations (0.5-100 mM). The temperature coefficients were determined by recording spectra of 1-2 mM solution of those compounds at seven different temperatures between 313-237 K. IR spectra were recorded on (FT-IR) Bruker IFS66 spectrophotometer. HRMS data were obtained on a MicroMass Autospec 3000 double focusing magnetic sector mass spectrometer operating at 3000 m/z with a cone voltage of 4V. Samples were introduced through an electrospray module (ESI).
Molecular
Modeling. Molecular models for compound 1 were generated using the MMFF94 force field as implemented in MacSpartan 10 1 . The initial geometries were then subjected to a conformational search on 52488 structures generated from all the rotatable bonds. The geometry of the two different conformers of minimum energy were then subjected to full geometry optimization at the RB3LYP/6-31G* level of approximation.
Synthesis of the Compounds
3-(Butylamino)-4-ethoxycyclobut-3-ene-1,2-dione (5) 5 was prepared as described previously 2 . 
2-((2-(

3-((2-(Butylamino)-3,4-dioxocyclobut-1-en-1-yl)amino)propanoic acid (10)
10 was prepared and purified as described for 9 starting from 5 (591 mg, 3.0 mmol), β- 
4-((2-(Butylamino)-3,4-dioxocyclobut-1-en-1-yl)amino)butanoic acid (11)
11 was prepared and purified as described for 9 starting from 5 (296 mg, 1.5 mmol), γ-aminobutiric acid (157 mg, 1.5 mmol) and sodium ethoxide (102 mg, 1.5 mmol 
(S)-Ethyl 2-(4-((2-(butylamino)-3,4-dioxocyclobut-1-en-1-yl)amino)butanamido)-3-phenylpropanoate (3)
3 was prepared and purified as described for 1 starting from 11 (509 mg, 2.0 mmol) phenylalanine methyl ester (663 mg, 3.7 mmol). The desired product 3 (556 mg, 
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Phenyl (1-((2-(tert-butoxycarbonyl)amino)ethyl)aminoethyl)amino)-4-methyl-1-oxopentan-2-yl)carbamate (12)
12 was prepared the coupling procedure described for 1 starting from N-tert-Buthyl- 
J=4.8Hz).
13 C RMN (CDCl 3 ) δ: 180. 6, 176.2, 175.0, 159.2, 138.9, 131.9, 130.6, 72.8, 69.8, 56.9, 47.1, 43.8, 42.4, 27.5, 25.7, 24.4, 18.5 172.0, 158.9, 140.7, 139.4, 131.1, 129.4, 81.2, 56.8, 50.6, 46.4, 35.3, 31.3, 28.3, 27.7, 27.6. IR (KBr): 3275, 2931 , 1680 , 1639 , 1546 . HRMS (ESI): m/z calc. for 175.5, 172.7, 171.8, 158.7, 140.9, 132.3, 131.2, 129.3, 80.6, 57.0, 50.7, 45.2, 35.5, 31.4, 28.9, 28.3, 27.7 
Benzyl ((S)-1-((2-((2-((4-((2-(((S
)
